Latest filing published 24 Jun 2026 for TALPHERA, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Stephen J. Hoffman is a declared insider at 2 companies (board member); the most frequent names are Talphera, Inc. and Dicerna Pharmaceuticals Inc. Between 3 June 2021 and 22 June 2026, the trades on record add up to 8 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 24 June 2026, the filings show a share grant in Talphera, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations